Coloplast A/S (OTCMKTS:CLPBY) Trading Down 2.3% – Here’s What Happened

Coloplast A/S (OTCMKTS:CLPBY)’s share price traded down 2.3% during mid-day trading on Thursday . The company traded as low as $11.49 and last traded at $11.49. 216,857 shares traded hands during trading, an increase of 70% from the average session volume of 127,904 shares. The stock had previously closed at $11.76.

Analysts Set New Price Targets

Separately, Hsbc Global Res upgraded shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research note on Monday, November 18th.

Coloplast A/S Stock Down 2.3 %

The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 1.00. The business’s fifty day simple moving average is $12.76 and its 200 day simple moving average is $12.86.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Tuesday, November 5th. The company reported $0.08 EPS for the quarter. Coloplast A/S had a return on equity of 31.17% and a net margin of 18.69%. The company had revenue of $1.02 billion during the quarter. As a group, research analysts anticipate that Coloplast A/S will post 0.37 EPS for the current year.

Coloplast A/S Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, December 20th. Stockholders of record on Monday, December 9th will be issued a dividend of $0.2435 per share. This is an increase from Coloplast A/S’s previous dividend of $0.05. The ex-dividend date is Monday, December 9th. Coloplast A/S’s payout ratio is currently 27.27%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.